VYOME HOLDINGS, INC. Payments for Restructuring
VYOME HOLDINGS, INC. (HIND) reported Payments for Restructuring of $819.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2021-03-12
- VYOME HOLDINGS, INC. payments for restructuring for the quarter ending 2019-09-30 was $144.00K.
- VYOME HOLDINGS, INC. payments for restructuring for fiscal 2019 was $819.00K.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 12 month |
|---|---|---|---|
| 2019-12-31 | $819.00K 10-K · filed 2021-03-12 | ||
| 2019-09-30 | $144.00K 10-Q · filed 2019-11-08 | ||
| 2019-06-30 | $537.00K 10-Q · filed 2019-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |